Apollo Tactical Income Fund Inc. Declares August 2020 Monthly Distribution of $0.068 Per Share
NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) — (NYSE: AIF) – Apollo Tactical Income Fund Inc. (the “Fund”) today announced […]
CrossAmerica Partners LP Reports Second Quarter 2020 Results
Allentown, PA, Aug. 06, 2020 (GLOBE NEWSWIRE) — CrossAmerica Partners LP Reports Second Quarter 2020 ResultsReported Second Quarter 2020 Operating […]
HCI Group Reports Second Quarter 2020 Results
TAMPA, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software […]
Apollo Senior Floating Rate Fund Inc. Declares August 2020 Monthly Distribution of $0.066 Per Share
NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) — (NYSE: AFT) – Apollo Senior Floating Rate Fund Inc. (the “Fund”) today […]
Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
— Expanded collaboration with partner Sanofi Pasteur for all infectious diseases further unites Translate Bio’s leading mRNA technology and large-scale […]
Evolving Systems Sets Date for 2020 Second Quarter Results News Release and Conference Call
ENGLEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) — Evolving Systems, Inc. (NASDAQ: EVOL), a leader in real-time digital engagement solutions […]
One Stop Systems Reports Q2 2020 Revenue of $11.6 Million with First Half 2020 of $25.0 Million
ESCONDIDO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS), a global leader in specialized high-performance […]
Applied Optoelectronics Reports Second Quarter 2020 Results
SUGAR LAND, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access […]
Datadog Announces Second Quarter Results
Second quarter revenue grew 68% year-over-year to $140 millionStrong growth of larger customers, with 1,015 $100k+ ARR customers, up from […]
IGM Biosciences Announces Second Quarter 2020 Financial Results and Provides Corporate Update
– IND for IGM-8444 for treatment of patients with solid cancers cleared by FDA –– Kathy Miller, Ph.D., appointed Vice […]
